Deutsche Bank’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$841K Buy
34,298
+11,202
+49% +$202K ﹤0.01% 2475
2026
Q1
$404K Buy
23,096
+7,300
+46% +$141K ﹤0.01% 2688
2025
Q4
$209K Sell
15,796
-9,529
-38% -$84.5K ﹤0.01% 2994
2025
Q3
$149K Hold
25,325
﹤0.01% 3192
2025
Q2
$105K Buy
25,325
+18,071
+249% +$72.8K ﹤0.01% 3234
2025
Q1
$27.3K Buy
+7,254
New +$33.5K ﹤0.01% 3456

Other funds holding BIOA

Deutsche Bank's BIOA Position: Q2 2026 in Review

Deutsche Bank increased its BioAge Labs (BIOA) stake by 49% in Q2 2026, buying an estimated $202K and bringing the position to 34,298 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Deutsche Bank first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Deutsche Bank held 34,298 shares of BioAge Labs worth $841K as of Q2 2026.
  • Deutsche Bank bought 11,202 BioAge Labs shares in Q2 2026, an estimated $202K.
  • BioAge Labs made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2475 holding.
  • Deutsche Bank first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 37 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.